Selected research
Industry Research
Potassium Iodide Radiation Tablets Industry Research Report 2026
Market perspective
The global Potassium Iodide Radiation Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Potassium Iodide Radiation Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Potassium Iodide Radiation Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Potassium Iodide Radiation Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Potassium Iodide Radiation Tablets include Anbex, BTG Specialty Pharmaceuticals, Healthvit, Hexagon Nutrition, KI Canada Ltd, Life Extension, NOW Foods, PCCA and Pure Encapsulations, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Potassium Iodide Radiation Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Potassium Iodide Radiation Tablets Market by Company
Anbex
BTG Specialty Pharmaceuticals
Healthvit
Hexagon Nutrition
KI Canada Ltd
Life Extension
NOW Foods
PCCA
Pure Encapsulations
Recipharm
Potassium Iodide Radiation Tablets Segment by Type
＜ 60mg
＞ 90mg
60 - 90mg
Potassium Iodide Radiation Tablets Segment by Application
Hospitals Pharmacies
Online Pharmacies
Retail Pharmacies
Potassium Iodide Radiation Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Potassium Iodide Radiation Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Potassium Iodide Radiation Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Potassium Iodide Radiation Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Potassium Iodide Radiation Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Potassium Iodide Radiation Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Potassium Iodide Radiation Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ＜ 60mg
- ＞ 90mg
- 60 - 90mg
Applications
- Hospitals Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Anbex
- BTG Specialty Pharmaceuticals
- Healthvit
- Hexagon Nutrition
- KI Canada Ltd
- Life Extension
- NOW Foods
- PCCA
- Pure Encapsulations
- Recipharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Potassium Iodide Radiation Tablets Market Size (2021-2032)
- 2.2.2 Global Potassium Iodide Radiation Tablets Sales (2021-2032)
- 2.2.3 Global Potassium Iodide Radiation Tablets Market Average Price (2021-2032)
- 2.3 Potassium Iodide Radiation Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 ＜ 60mg
- 2.3.3 ＞ 90mg
- 2.3.4 60 - 90mg
- 2.4 Potassium Iodide Radiation Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Potassium Iodide Radiation Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Potassium Iodide Radiation Tablets Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Potassium Iodide Radiation Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Potassium Iodide Radiation Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Potassium Iodide Radiation Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Potassium Iodide Radiation Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Potassium Iodide Radiation Tablets, Product Type & Application
- 3.8 Global Manufacturers of Potassium Iodide Radiation Tablets, Established Date
- 3.9 Global Potassium Iodide Radiation Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Anbex
- 4.1.1 Anbex Company Information
- 4.1.2 Anbex Business Overview
- 4.1.3 Anbex Potassium Iodide Radiation Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Anbex Potassium Iodide Radiation Tablets Product Portfolio
- 4.1.5 Anbex Recent Developments
- 4.2 BTG Specialty Pharmaceuticals
- 4.2.1 BTG Specialty Pharmaceuticals Company Information
- 4.2.2 BTG Specialty Pharmaceuticals Business Overview
- 4.2.3 BTG Specialty Pharmaceuticals Potassium Iodide Radiation Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BTG Specialty Pharmaceuticals Potassium Iodide Radiation Tablets Product Portfolio
- 4.2.5 BTG Specialty Pharmaceuticals Recent Developments
- 4.3 Healthvit
- 4.3.1 Healthvit Company Information
- 4.3.2 Healthvit Business Overview
- 4.3.3 Healthvit Potassium Iodide Radiation Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Healthvit Potassium Iodide Radiation Tablets Product Portfolio
- 4.3.5 Healthvit Recent Developments
- 4.4 Hexagon Nutrition
- 4.4.1 Hexagon Nutrition Company Information
- 4.4.2 Hexagon Nutrition Business Overview
- 4.4.3 Hexagon Nutrition Potassium Iodide Radiation Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hexagon Nutrition Potassium Iodide Radiation Tablets Product Portfolio
- 4.4.5 Hexagon Nutrition Recent Developments
- 4.5 KI Canada Ltd
- 4.5.1 KI Canada Ltd Company Information
- 4.5.2 KI Canada Ltd Business Overview
- 4.5.3 KI Canada Ltd Potassium Iodide Radiation Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 KI Canada Ltd Potassium Iodide Radiation Tablets Product Portfolio
- 4.5.5 KI Canada Ltd Recent Developments
- 4.6 Life Extension
- 4.6.1 Life Extension Company Information
- 4.6.2 Life Extension Business Overview
- 4.6.3 Life Extension Potassium Iodide Radiation Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Life Extension Potassium Iodide Radiation Tablets Product Portfolio
- 4.6.5 Life Extension Recent Developments
- 4.7 NOW Foods
- 4.7.1 NOW Foods Company Information
- 4.7.2 NOW Foods Business Overview
- 4.7.3 NOW Foods Potassium Iodide Radiation Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 NOW Foods Potassium Iodide Radiation Tablets Product Portfolio
- 4.7.5 NOW Foods Recent Developments
- 4.8 PCCA
- 4.8.1 PCCA Company Information
- 4.8.2 PCCA Business Overview
- 4.8.3 PCCA Potassium Iodide Radiation Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 PCCA Potassium Iodide Radiation Tablets Product Portfolio
- 4.8.5 PCCA Recent Developments
- 4.9 Pure Encapsulations
- 4.9.1 Pure Encapsulations Company Information
- 4.9.2 Pure Encapsulations Business Overview
- 4.9.3 Pure Encapsulations Potassium Iodide Radiation Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pure Encapsulations Potassium Iodide Radiation Tablets Product Portfolio
- 4.9.5 Pure Encapsulations Recent Developments
- 4.10 Recipharm
- 4.10.1 Recipharm Company Information
- 4.10.2 Recipharm Business Overview
- 4.10.3 Recipharm Potassium Iodide Radiation Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Recipharm Potassium Iodide Radiation Tablets Product Portfolio
- 4.10.5 Recipharm Recent Developments
5 Global Potassium Iodide Radiation Tablets Market Scenario by Region
- 5.1 Global Potassium Iodide Radiation Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Potassium Iodide Radiation Tablets Sales by Region: 2021-2032
- 5.2.1 Global Potassium Iodide Radiation Tablets Sales by Region: 2021-2026
- 5.2.2 Global Potassium Iodide Radiation Tablets Sales by Region: 2027-2032
- 5.3 Global Potassium Iodide Radiation Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Potassium Iodide Radiation Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Potassium Iodide Radiation Tablets Revenue by Region: 2027-2032
- 5.4 North America Potassium Iodide Radiation Tablets Market Facts & Figures by Country
- 5.4.1 North America Potassium Iodide Radiation Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Potassium Iodide Radiation Tablets Sales by Country (2021-2032)
- 5.4.3 North America Potassium Iodide Radiation Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Potassium Iodide Radiation Tablets Market Facts & Figures by Country
- 5.5.1 Europe Potassium Iodide Radiation Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Potassium Iodide Radiation Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Potassium Iodide Radiation Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Potassium Iodide Radiation Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Potassium Iodide Radiation Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Potassium Iodide Radiation Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Potassium Iodide Radiation Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Potassium Iodide Radiation Tablets Market Facts & Figures by Country
- 5.7.1 South America Potassium Iodide Radiation Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Potassium Iodide Radiation Tablets Sales by Country (2021-2032)
- 5.7.3 South America Potassium Iodide Radiation Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Potassium Iodide Radiation Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Potassium Iodide Radiation Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Potassium Iodide Radiation Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Potassium Iodide Radiation Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Potassium Iodide Radiation Tablets Sales by Type (2021-2032)
- 6.1.1 Global Potassium Iodide Radiation Tablets Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Potassium Iodide Radiation Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Potassium Iodide Radiation Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Potassium Iodide Radiation Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Potassium Iodide Radiation Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Potassium Iodide Radiation Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Potassium Iodide Radiation Tablets Sales by Application (2021-2032)
- 7.1.1 Global Potassium Iodide Radiation Tablets Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Potassium Iodide Radiation Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Potassium Iodide Radiation Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Potassium Iodide Radiation Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Potassium Iodide Radiation Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Potassium Iodide Radiation Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Potassium Iodide Radiation Tablets Value Chain Analysis
- 8.1.1 Potassium Iodide Radiation Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Potassium Iodide Radiation Tablets Production Mode & Process
- 8.2 Potassium Iodide Radiation Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Potassium Iodide Radiation Tablets Distributors
- 8.2.3 Potassium Iodide Radiation Tablets Customers
9 Global Potassium Iodide Radiation Tablets Analyzing Market Dynamics
- 9.1 Potassium Iodide Radiation Tablets Industry Trends
- 9.2 Potassium Iodide Radiation Tablets Industry Drivers
- 9.3 Potassium Iodide Radiation Tablets Industry Opportunities and Challenges
- 9.4 Potassium Iodide Radiation Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst